BioAdaptives, Inc. (BDPT) stock
BDPTOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00−0.00 (-5.56%)
Close on Oct 19, 2026Market cap $478.03KP/E –Yield –
BioAdaptives operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
BioAdaptives's operating cash flow for the twelve months ending Jun 30, 2026 was -$436.36K. For fiscal 2025 it was -$516.03K. The highest annual figure on record is -$72 in fiscal 2015.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$516.03K | – |
| FY2024 | Dec 31, 2024 | -$249.52K | – |
| FY2023 | Dec 31, 2023 | -$223.77K | – |
| FY2022 | Dec 31, 2022 | -$227.26K | – |
| FY2021 | Dec 31, 2021 | -$158.65K | – |
| FY2020 | Dec 31, 2020 | -$106.89K | – |
| FY2019 | Dec 31, 2019 | -$168.12K | – |
| FY2018 | Dec 31, 2018 | -$420.15K | – |
| FY2015 | Dec 31, 2015 | -$72 | – |
| FY2014 | Dec 31, 2014 | -$58.63K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$44.39K | – |
| Q1 FY2026 | Mar 31, 2026 | -$84.84K | – |
| Q4 FY2025 | Dec 31, 2025 | -$155.83K | – |
| Q3 FY2025 | Sep 30, 2025 | -$151.31K | – |
| Q2 FY2025 | Jun 30, 2025 | -$110.98K | – |
| Q1 FY2025 | Mar 31, 2025 | -$97.91K | – |
| Q4 FY2024 | Dec 31, 2024 | -$100.54K | – |
| Q3 FY2024 | Sep 30, 2024 | -$56.34K | – |
| Q2 FY2024 | Jun 30, 2024 | -$51.46K | – |
| Q1 FY2024 | Mar 31, 2024 | -$41.18K | – |
| Q4 FY2023 | Dec 31, 2023 | -$91.30K | – |
| Q3 FY2023 | Sep 30, 2023 | -$56.15K | – |
| Q2 FY2023 | Jun 30, 2023 | -$56.87K | – |
| Q1 FY2023 | Mar 31, 2023 | -$19.46K | – |
| Q4 FY2022 | Dec 31, 2022 | -$27.50K | – |
| Q3 FY2022 | Sep 30, 2022 | -$61.54K | – |
| Q2 FY2022 | Jun 30, 2022 | -$77.06K | – |
| Q1 FY2022 | Mar 31, 2022 | -$61.16K | – |
| Q4 FY2021 | Dec 31, 2021 | -$35.40K | – |
| Q3 FY2021 | Sep 30, 2021 | -$33.17K | – |
| Q2 FY2021 | Jun 30, 2021 | -$29.71K | – |
| Q1 FY2021 | Mar 31, 2021 | -$60.36K | – |
| Q4 FY2020 | Dec 31, 2020 | -$9.86K | – |
| Q3 FY2020 | Sep 30, 2020 | -$34.48K | – |
| Q2 FY2020 | Jun 30, 2020 | -$20.23K | – |
| Q1 FY2020 | Mar 31, 2020 | -$42.31K | – |
| Q4 FY2019 | Dec 31, 2019 | -$76.40K | -747.0% |
| Q3 FY2019 | Sep 30, 2019 | -$32.37K | – |
| Q2 FY2019 | Jun 30, 2019 | -$12.45K | – |
| Q1 FY2019 | Mar 31, 2019 | -$46.90K | -5104.9% |
| Q3 FY2016 | Sep 30, 2016 | $11.81K | +7772.7% |
| Q2 FY2016 | Jun 30, 2016 | -$209 | – |
| Q1 FY2016 | Mar 31, 2016 | -$1.71K | – |
| Q4 FY2015 | Dec 31, 2015 | $937 | – |
| Q3 FY2015 | Sep 30, 2015 | $150 | – |
See a number that looks wrong?